Astrana Health, Inc. (ASTH)

Astrana Health Stock Forecast

Stock Price Forecast

The 8 analysts that cover Astrana Health stock have a consensus rating of "Strong Buy" and an average price target of $53.29, which forecasts a 115.49% increase in the stock price over the next year. The lowest target is $36 and the highest is $70.

Price Target: $53.29 (+115.49%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$36	$53.29	$50	$70
Change	+45.57%	+115.49%	+102.18%	+183.06%

* Price targets were last updated on Apr 1, 2025.

Analyst Ratings

The average analyst rating for Astrana Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	4	4	5	5	5	5
Buy	1	1	1	1	1	1
Hold	1	1	1	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	7	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andrew Mok Barclays	Barclays	Hold Initiates $36	Hold	Initiates	$36	+45.57%	Apr 1, 2025
Jailendra Singh Truist Securities	Truist Securities	Strong Buy Maintains $50 → $46	Strong Buy	Maintains	$50 → $46	+86.01%	Mar 18, 2025
Adam Ron B of A Securities	B of A Securities	Strong Buy Maintains $55 → $49	Strong Buy	Maintains	$55 → $49	+98.14%	Mar 4, 2025
Michael Ha Baird	Baird	Buy Maintains $86 → $50	Buy	Maintains	$86 → $50	+102.18%	Mar 3, 2025
Craig Jones Stifel	Stifel	Strong Buy Maintains $70 → $56	Strong Buy	Maintains	$70 → $56	+126.45%	Feb 20, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.75B

Increased by 34.97%

from 2.03B

Revenue Next Year

3.34B

Increased by 21.52%

from 2.75B

EPS This Year

1.12

Increased by 24.88%

from 0.90

EPS Next Year

1.58

Increased by 40.39%

from 1.12

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	687.18M	773.92M	1.14B	1.39B	2.03B	2.75B	3.34B	3.98B
Revenue Growth	22.58%	12.62%	47.84%	21.19%	46.72%	34.97%	21.52%	19.24%
EPS	1.01	1.52	0.99	1.29	0.90	1.12	1.58	2.35
EPS Growth	158.97%	50.50%	-34.87%	30.30%	-30.23%	24.88%	40.39%	48.88%
Forward PE	-	-	-	-	-	22.00	15.67	10.53
No. Analysts	-	-	-	-	-	14	13	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	3.4B	4.3B	4.7B
Avg	2.7B	3.3B	4.0B
Low	2.5B	2.8B	3.3B

Revenue Growth

Revenue Growth	2025	2026	2027
High	65.0%	55.6%	42.3%
Avg	35.0%	21.5%	19.2%
Low	22.8%	2.0%	-0.1%

EPS Forecast

EPS	2025	2026	2027
High	1.40	2.56	3.39
Avg	1.12	1.58	2.35
Low	0.80	0.33	0.90

EPS Growth

EPS Growth	2025	2026	2027
High	55.2%	127.5%	115.1%
Avg	24.9%	40.4%	48.9%
Low	-10.7%	-70.5%	-42.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.